Skip to main content
. 2018 Oct 31;120(1):57–62. doi: 10.1038/s41416-018-0234-3

Table 2.

Response to treatment

Response, n (%) KRAS-positive (n = 206) KRAS-negative (n = 324) P-value
ORR 41 (20) 55 (17) 0.39
DCR 96 (47) 134 (41) 0.23
Best overall response
  CR 2 (1) 1 (<1)
  PR 39 (19) 54 (17)
  SD 55 (27) 79 (24)
  PD 88 (43) 153 (47)
  Death 12 (5) 30 (9)
  Not determined 10 (5) 7 (2)

n number of patients, ORR objective response rate, DCR disease control rate, CR complete response, PR partial response, SD stable disease, PD progression disease